Cargando…
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
The present-day world is severely suffering from the recently emerged SARS-CoV-2. The lack of prescribed drugs for the deadly virus has stressed the likely need to identify novel inhibitors to alleviate and stop the pandemic. In the present high throughput virtual screening study, we used in silico...
Autores principales: | Naik, Biswajit, Gupta, Nidhi, Ojha, Rupal, Singh, Satyendra, Prajapati, Vijay Kumar, Prusty, Dhaneswar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250083/ https://www.ncbi.nlm.nih.gov/pubmed/32470577 http://dx.doi.org/10.1016/j.ijbiomac.2020.05.184 |
Ejemplares similares
-
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
por: Ojha, Rupal, et al.
Publicado: (2020) -
Strategic Development of a Next-Generation Multi-Epitope
Vaccine To Prevent Nipah Virus Zoonotic Infection
por: Ojha, Rupal, et al.
Publicado: (2019) -
Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study
por: Srivastava, Varshita, et al.
Publicado: (2023) -
Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach
por: Singh, Swati, et al.
Publicado: (2022) -
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
por: Ojha, Rupal, et al.
Publicado: (2023)